- Home
- AMTB vs MDXG Comparison
AMTB vs MDXG Comparison
Compare AMTB & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMTB | MDXG |
|---|---|---|
| Founded | 1979 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 974.4M | 1.0B |
| IPO Year | 2018 | 2007 |
Fundamental Metrics
Financial Performance| Metric | AMTB | MDXG |
|---|---|---|
| Price | $23.35 | $3.62 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $23.67 | $9.00 |
| AVG Volume (30 Days) | 234.8K | ★ 1.8M |
| Earning Date | 04-23-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.57% | N/A |
| EPS Growth | ★ 386.36 | 14.29 |
| EPS | ★ 0.44 | N/A |
| Revenue | N/A | ★ $418,630,000.00 |
| Revenue This Year | $8.29 | N/A |
| Revenue Next Year | $7.67 | $13.02 |
| P/E Ratio | $53.02 | ★ N/A |
| Revenue Growth | N/A | ★ 19.99 |
| 52 Week Low | $15.62 | $3.03 |
| 52 Week High | $24.38 | $7.99 |
Technical Indicators
Market Signals| Indicator | AMTB | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 55.82 | 47.86 |
| Support Level | $21.98 | $3.11 |
| Resistance Level | $24.02 | $7.39 |
| Average True Range (ATR) | 0.63 | 0.18 |
| MACD | -0.05 | 0.07 |
| Stochastic Oscillator | 68.97 | 84.40 |
Price Performance
Historical ComparisonAbout AMTB Amerant Bancorp Inc.
Amerant Bancorp Inc is a bank holding company. Through its bank, it provides individuals and businesses deposit, credit, investment, wealth management, and fiduciary services, both in the United States and to select international customers. The bank also provides banking services through traditional channels, such as banking centers and ATMs, as well as via secure websites, mobile devices and telephones.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.